Rhythm Pharmaceuticals (RYTM) Raw Materials (2022 - 2025)

Rhythm Pharmaceuticals (RYTM) has 4 years of Raw Materials data on file, last reported at $7.2 million in Q3 2025.

• On a quarterly basis, Raw Materials rose 43.01% year-over-year to $7.2 million in Q3 2025; TTM through Sep 2025 was $7.2 million, a 43.01% increase from a year earlier, with the FY2024 full-year figure at $6.8 million, up 46.51% from the prior year.
• Raw Materials for Q3 2025 stood at $7.2 million, up from $4.5 million in the prior quarter.
• Over the last five years, Raw Materials for RYTM reached as high as $7.2 million in Q3 2025 and fell as low as $2.3 million in Q2 2023.
• Historically, Raw Materials has averaged $4.4 million across 4 years, with a median of $4.6 million in 2023.
• On a YoY basis, Raw Materials climbed as much as 82.2% in 2024 and fell as far as 31.3% in 2024.
• Year by year, Raw Materials stood at $2.7 million in 2022, then surged by 69.91% to $4.6 million in 2023, then jumped by 46.51% to $6.8 million in 2024, then increased by 5.95% to $7.2 million in 2025.
• Per Business Quant data, the three most recent Raw Materials figures were $7.2 million in Q3 2025, $4.5 million in Q2 2025, and $5.0 million in Q1 2025.